PMRS Continues Campaign Against Other Abuse Deterrent Opioid Products

 
• By Brenda Sandburg

Latest citizen petition seeks to halt US FDA approval of Mallinckrodt's immediate release oxycodone abuse deterrent formulation; user fee action date is Nov. 16.

Opioid Oxycodone crushed

More from Product Reviews

More from Pink Sheet